Month: October 2021

Blog article

Healthcare’s supply chain poses the next big environmental challenge

Healthcare companies in recent years have largely focused on reducing greenhouse gas emissions as they strive to become more environmentally sustainable. While that focus has produced several innovations in conservation and alternative energy use, critics argue those actions have only scratched the surface of reducing healthcare’s climate footprint.

Hospitals have remained one of the world’s largest polluters despite increased calls to address climate change. Healthcare greenhouse emissions rose 6% from 2012 to 2018, according to a December 2020 Health Affairs study. As a whole, the industry now makes up more than 8% of all U.S. emissions.

“The healthcare sector has been a real laggard in terms of climate,” said Jessica Wolff, director of climate and health for Health Care Without Harm, an international advocacy organization that promotes ecological healthcare practices. “In corporate America, many, many companies have done full greenhouse gas inventories and set ambitious goals—that’s not the case with

Read More
Health News

Aromatherapy spray linked to US deaths faces recall

This undated photo provided by Walmart and the U.S. Centers for Disease Control and Prevention shows a bottle of Better Homes & Gardens aromatherapy lavender & chamomile essential oil and semiprecious stone-infused room spray. The Consumer Product Safety Commission and Walmart issued a recall Friday, Oct. 22. 2021, for 3,900 bottles of the spray. Credit: Walmart/CDC via AP

U.S. health officials may have solved the mystery of how four people in different states came down with a serious tropical disease even though none had traveled internationally: an aromatherapy spray imported from India.

The Centers for Disease Control and Prevention said Friday that investigators found the same type of bacteria that causes the disease, melioidosis, in a spray bottle found in one of the patients’ homes.

The four people were from Georgia, Kansas, Minnesota and Texas. Two of them, one a child in Georgia, died.

The agency said it was testing

Read More
Blog article

Cerner to lay off 150 workers next month

New Cerner CEO Dr. David Feinberg on Thursday told employees that a set of layoffs will take place in November, a company spokesperson confirmed to Modern Healthcare.

Feinberg, who took the helm as Cerner’s CEO on Oct. 1 following nearly three years leading Google Health, sent an email to employees Thursday evening after noticing a comment on Reddit, according to the Kansas City Star, which first reported the news. The Reddit commenter had said they were a company employee that recently learned they would be laid off.

“You will always get transparency from me,” Feinberg wrote in the email, according to the Kansas City Star. “Although I would have liked to be the first to inform you, I can confirm, in early November, approximately 150 positions will be eliminated from their roles at Cerner. These actions are never easy.”

Cerner did not respond to questions regarding what departments would

Read More
Health News

mRNA vaccine more effective booster to ChAdOx1 nCoV-19

(HealthDay)—Use of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination is more effective than homologous ChAdOx1 nCoV-19/ChAdOx1 nCoV-19 prime-boost vaccination, according to a study published online Oct. 17 in The Lancet Regional Health: Europe.

Peter Nordström, M.D., Ph.D., from Umeå University in Sweden, and colleagues examined the effectiveness of heterologous prime-boost COVID-19 vaccination among individuals in Sweden who had received two doses of COVID-19 by July 5, 2021. The study cohort included 94,569 individuals who received heterologous ChAdOx1 nCoV-19/BNT162b2 prime-boost vaccination, 16,402 individuals who received ChAdOx1 nCoV-19/mRNA-1273 prime-boost vaccination, and 430,100 individuals who received homologous ChAdOx1 nCoV-19/ChAdOx1 nCoV-19 prime-boost vaccination. Furthermore, 180,716 individuals were selected who were unvaccinated at the vaccination date of the corresponding case.

The researchers confirmed symptomatic COVID-19 infection in 187 individuals with heterologous vaccine schedules (incidence rate, 2.0/100,000 person-days) and in 306 individuals from the unvaccinated control group (incidence rate, 7.1 per 100,000 person-days) during

Read More
Blog article

Expert panel takes up complicated COVID-19 booster questions

Influential government advisers are deciding Thursday how best to expand the nation’s COVID-19 booster campaign, including whether and when it’s OK to “mix and match” brands for the extra dose.

The advisers to the Centers for Disease Control and Prevention are slated to discuss who should get extra doses of the Moderna or Johnson & Johnson vaccines — and the bigger question of getting a different brand for the booster than people’s original vaccination.

The Food and Drug Administration authorized both steps Wednesday, as part of a federal push to broaden booster access for the U.S. public. But the CDC, guided by its advisory panel, provides the final blessing.

About two-thirds of Americans eligible for COVID-19 shots are fully vaccinated, and several million have gotten additional doses of Pfizer’s vaccine after the FDA and CDC gave that go-ahead last month. While health authorities hope boosters will shore up waning immunity

Read More
Health News

Moving monoclonal antibody treatments for COVID from hospital to home

(HealthDay)—Antibody infusions help keep high-risk COVID-19 patients out of the hospital, but getting the therapy can be a challenge. One U.S. health system has found a creative way to address the problem: home infusions administered by paramedics. They delivered antibody infusions to 144 COVID-19 patients in their homes over three months earlier this year.

Most—about 95%—avoided hospitalization for worsening COVID-19 symptoms.

While COVID-19 hospitalizations have been declining recently, the United States is still averaging more than 6,600 new hospital admissions for the infection each day, according to the U.S. Centers for Disease Control and Prevention.

When people at high risk of severe COVID-19 do contract the virus, there is a way to lower their odds of ending up in the hospital: an of monoclonal .

Monoclonal antibodies are lab-engineered proteins that are similar to the antibodies the immune system churns out to fight infection. Those used against COVID-19

Read More